Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings
2010/11/10 by Laia Bruni, Mireia Díaz, Mireia Diaz +5 · 28 citations
Medicine · Immunology and Microbiology · #Cervical Cancer and HPV Research #Head and Neck Cancer Studies #Reproductive tract infections research
paper · doi:10.1086/657321
Abstract
BACKGROUND: Baseline information on human papillomavirus (HPV) prevalence and type distribution is highly desirable to evaluate the impact of prophylactic HPV vaccines in the near future. METHODS: A meta-analysis was performed of studies published between 1995 and 2009 that used polymerase chain reaction or Hybrid Capture 2 for HPV detection in women with normal cytological findings. RESULTS: The analysis included 194 studies comprising 1,016,719 women with normal cytological findings. The estimated global HPV prevalence was 11.7% (95% confidence interval, 11.6%-11.7%). Sub-Saharan Africa (24.0%), Eastern Europe (21.4%), and Latin America (16.1%) showed the highest prevalences. Age-specific HPV distribution presented with a first peak at younger ages (<25 years) and, in the Americas and Africa, a rebound at older ages (≥45 years). Among the women with type-specific HPV data (n = 215,568), the 5 most common types worldwide were HPV-16 (3.2%), HPV-18 (1.4%), HPV-52 (0.9%), HPV-31 (0.8%), and HPV-58 (0.7%). CONCLUSIONS: Although the prevalence of HPV in women with normal cytological findings is high and variable across world regions, HPV types 16, 18, 31, 52, and 58 are consistently found among the 10 most common types in all of them. These results represent the most comprehensive assessment of HPV burden among women with normal cytological findings in the pre-HPV vaccination era worldwide.
Cited by
- Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials
- Prevalence and genotype distribution of high-risk human papillomavirus infection among Chinese women aged 35–64: A national screening population-based study
- Viral Infections and Risk of Cardiovascular Disease: Systematic Review and Meta‐Analysis
- A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? [europepmc]
- A review of methods for detect human Papillomavirus infection. [europepmc]
- The burden of human papillomavirus infections and related diseases in sub-saharan Africa. [europepmc]
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. [europepmc]
- Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology. [europepmc]
- Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis. [europepmc]
- Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. [europepmc]
- The role of infection in miscarriage. [europepmc]
- Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. [europepmc]
- Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females. [europepmc]
- Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota. [europepmc]
- Relationship between human papillomavirus and penile cancer-implications for prevention and treatment. [europepmc]
- Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. [europepmc]
- Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review). [europepmc]
- Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance site. [europepmc]
- Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. [europepmc]
- Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives. [europepmc]
- Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. [europepmc]
- Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. [europepmc]
- Cervical cancer in low and middle-income countries. [europepmc]
- Cervical cancer: Epidemiology, risk factors and screening. [europepmc]
- Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. [europepmc]
- Cervical cancer therapies: Current challenges and future perspectives. [europepmc]
- Cancer cervix: Epidemiology and disease burden. [europepmc]
- Sexually transmitted infections and female reproductive health. [europepmc]
Related